Schedule 13G ownership disclosure
ETERNA THERAPEUTICS INC
Common Stock, par value $0.005 per share · CUSIP: 114082209
Event date: 2024-10-29
- Filing-level shares
- 2,679,214.00
- Percent of class
- 5.22%
- IAF, LLC
Shares: 2,679,214.00 · Class: 5.22%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-012308
- Form type
- SCHEDULE 13G/A
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- Feb 12, 2025
- Reporting period
- Oct 29, 2024
- Description
- Schedule 13G beneficial ownership